RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION
- 1 December 1981
- journal article
- research article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 91 (3) , 457-465
- https://doi.org/10.1677/joe.0.0910457
Abstract
The plasma concentration of aldosterone was followed in seven hypertensive patients before and during long-term angiotensin II suppression with the orally active angiotensin-I-converting-enzyme inhibitor, captopril. The plasma concentration of aldosterone decreased initially from 74 to 21 pg/ml (P < 0·05) after 1 month of administration of captopril. Thereafter the plasma concentration of aldosterone began to rise and after 1 year reached a level of 165 pg/ml. During long-term captopril therapy the plasma renin activity remained increased and the plasma angiotensin II concentration suppressed. The mechanism responsible for the late rise of the plasma concentration of aldosterone during long-term angiotensin II suppression with captopril remains to be elucidated. A sizeable and lasting hypotensive effect was observed in all patients.This publication has 6 references indexed in Scilit:
- Dose response in captopril therapy of hypertensionClinical Pharmacology & Therapeutics, 1980
- The Effect of Captopril on Blood Pressure and Angiotensins I, II and III in Sodium-Depleted Dogs: Problems Associated with the Measurement of Angiotensin II after Inhibition of Converting EnzymeClinical Science, 1980
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Angiotensin II/Aldosterone Dose-Response Curves in the Dog: Effect of Changes in Sodium BalanceEndocrinology, 1978
- Faster radioimmunoassay of angiotensin I at 37 degrees C.Clinical Chemistry, 1978
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977